Concepedia

Author

Marius Ilié

InsermORCID

Also Known As

Ilie M., Ilie, Marius, Ilié, Marius, M Ilie, M İlie, M. I. Ilie, M. Ilie, M. Ilié, M.-I. Ilie, M.I. Ilie

361

Publications

9.6K

Citations

53

H-Index

110

Concepts

All Affiliations

InsermUniversité Côte d'AzurHôpital PasteurInstitut de Recherche sur le Cancer et le Vieillissement de NiceCentre National de la Recherche Scientifique
MI

About

Marius Ilié is an author at Inserm specializing in medicine, pathology, and lung cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

29

48

3.7K

2

Health Sciences

9

10

859

3

Engineering

5

5

287

4

Public Health

2

2

31

5

Natural Sciences

1

1

45

Marius Ilié

×

104

Publications

7K

Citations

47

H-Index

YearCitations

Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies

Marius Ilié, Élodie Long-Mira, Coraline Bence,

Annals of Oncology

2015

566

“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease

Marius Ilié, Véronique Hofman, Élodie Long-Mira,

PLoS ONE

2014

413

Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker

Véronique Hofman, Christelle Bonnetaud, Marius Ilié,

Clinical Cancer Research

2010

312

Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non‐small‐cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method

Véronique Hofman, Marius Ilié, Élodie Long-Mira,

International Journal of Cancer

2010

300

Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer

Marius Ilié, Edith Szafer‐Glusman, Véronique Hofman,

Annals of Oncology

2017

196

Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes

Haissi Cui, Bastian Seubert, Elizabeth C. Stahl,

Oncogene

2014

190

Predictive clinical outcome of the intratumoral CD66b‐positive neutrophil‐to‐CD8‐positive T‐cell ratio in patients with resectable nonsmall cell lung cancer

Marius Ilié, Véronique Hofman, Cécile Ortholan,

Cancer

2011

183

High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer

Marius Ilié, Nathalie M. Mazure, Véronique Hofman,

British Journal of Cancer

2010

182

Fibronectin-guided migration of carcinoma collectives

Sandeep Gopal, Laurence Veracini, Dominique Grall,

Nature Communications

2017

177

Two Panels of Plasma MicroRNAs as Non-Invasive Biomarkers for Prediction of Recurrence in Resectable NSCLC

C. Sanfiorenzo, Marius Ilié, Amine Belaïd,

PLoS ONE

2013

172

Page 1